News
Spinout
Invizius wins second Biomedical Catalyst Grant to take H-Guard into new field
Invizius, the biotechnology spinout company developing treatments to suppress unwanted immune responses in dialysis, has been awarded a second Biomedical Catalyst grant by Innovate UK to research a new field of application for its H-Guard® technology.

